Skip to main content
. 2022 Feb 10;32(2):196–205. doi: 10.1089/thy.2021.0304

Table 2.

Serum Triiodothyronine in Volunteers During 48 Hours After Taking a Capsule of Poly-Zinc-Liothyronine, L-triiodothyronine, or Placebo

Time (hours) PZL (ng/dL)
LT3 (ng/dL)
PB (ng/dL)
n
Mean SEM Mean SEM Mean SEM
−0.5 109 5.1 115 7.1 114 4.6 9
−0.25 108 5.2 110 6.2 111 4.9 9
1 122 11.6 140 9.5 108 4.5 9
2 208 40.2 298 37.5** 105 3.8 9
3 230 35.9 304 29.4* 102 3.4 9
4 221 26.3 265 25.3 101 3.5 9
6 221 22.0 205 16.1 100 4.4 9
8 203 18.9 178 13.1 101 5.5 9
12 165 14.6 141 8.5 100 5.6 9
18 147 12.1 129 7.3 102 5.2 9
24 143 12.4 122 5.2 99 4.6 9
36 110 7.0 102 6.0 97 6.5 9
46 102 6.3 100 4.8 97 6.2 9
*

p < 0.05 versus PZL; **p < 0.01 versus PZL by two-way ANOVA; normal reference range is 80–200 ng/dL.

ANOVA, analysis of variance; LT3, L-triiodothyronine; PZL, poly-zinc-liothyronine; SEM, standard error of mean.